Ageogen
AI-powered platform for discovering and developing novel therapeutics for age-related diseases.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does Ageogen do?
Ageogen is an AI-driven biotechnology company focused on accelerating the discovery and development of novel therapeutics for age-related diseases. Their platform leverages advanced machine learning and computational biology to identify promising drug candidates and optimize their development pathways, aiming to bring effective treatments to patients faster.
How much funding has Ageogen raised?
Ageogen has raised a total of $12M in funding. The most recent round on record is Seed.
Where is Ageogen headquartered?
Ageogen is headquartered in San Francisco, United States.
When was Ageogen founded?
Ageogen was founded in 2021.
What industry does Ageogen operate in?
Ageogen operates in Biotech, HealthTech, Drug Discovery, Longevity, AI-Driven Protein Design, Genomics.